Fostering Pediatric Oncology Drug Development
Our speakers will discuss the pediatric oncology regulatory landscape and how modeling and simulation is used in pediatric oncology drug development.
Tag: PK/PDモデリング＆シミュレーション
Trial Simulator for NONMEM Modelers
Examples Guide Version 1 Applies to: Trial Simulator 2.3, NONMEM 7.3 As a courtesy to Certara’s Trial Simulator users, we have created this guide with 23 hypothetical examples where NONMEM codes and the corresponding TS codes are provided so that users may use these examples as templates to enter their models into Trial Simulator for … Continued
Accelerating Vaccine Development: Applications to COVID-19 and Future Pandemics
Certara Launches Version 8.3 of Phoenix™ Biosimulation Software for Drug Development
Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.—2020年6月24日. Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and … Continued
Phoenix PK/PD Platform
Phoenix WinNonlin
Certara Integral データレポジトリ
COVID-19の治療薬開発を加速
This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.
